Trials / Available
AvailableNCT05041036
Individual Patient Compassionate Use of Nirogacestat
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- SpringWorks Therapeutics, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee, and applicable competent authority approval.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nirogacestat (Gamma Secretase Inhibitor) | Patients will receive nirogacestat tablets to be taken orally. |
Timeline
- First posted
- 2021-09-10
- Last updated
- 2026-04-01
Source: ClinicalTrials.gov record NCT05041036. Inclusion in this directory is not an endorsement.